| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.CARDIORES.2006.07.012 |
| P698 | PubMed publication ID | 16919613 |
| P2093 | author name string | Andrew Leask | |
| P433 | issue | 2 | |
| P304 | page(s) | 207-212 | |
| P577 | publication date | 2006-07-21 | |
| P1433 | published in | Cardiovascular Research | Q4642329 |
| P1476 | title | TGFbeta, cardiac fibroblasts, and the fibrotic response | |
| P478 | volume | 74 |
| Q55655940 | 3D Cell Migration Studies for Chemotaxis on Microfluidic-Based Chips: A Comparison between Cardiac and Dermal Fibroblasts. |
| Q34349864 | A novel immunomodulator, FTY-720 reverses existing cardiac hypertrophy and fibrosis from pressure overload by targeting NFAT (nuclear factor of activated T-cells) signaling and periostin |
| Q49817469 | A review of Chinese herbal medicine for the treatment of chronic heart failure. |
| Q39914658 | A synthetic peptide from transforming growth factor-beta1 type III receptor prevents myocardial fibrosis in spontaneously hypertensive rats |
| Q37200225 | Air pollution and cardiac remodeling: a role for RhoA/Rho-kinase. |
| Q52660924 | Alpha-linolenic acid protects against cardiac injury and remodelling induced by beta-adrenergic overstimulation. |
| Q35916617 | Ameliorative effects of Xue-Fu-Zhu-Yu decoction, Tian-Ma-Gou-Teng-Yin and Wen-Dan decoction on myocardial fibrosis in a hypertensive rat mode |
| Q28583081 | Angiotensin II increases periostin expression via Ras/p38 MAPK/CREB and ERK1/2/TGF-β1 pathways in cardiac fibroblasts |
| Q27690277 | Arrhythmogenic right ventricular dysplasia/cardiomyopathy type 1: a light on molecular mechanisms |
| Q38967954 | Basic Signaling in Cardiac Fibroblasts |
| Q84310802 | Bioengineering the infarcted heart by applying bio-inspired materials |
| Q34923598 | Biventricular remodeling in murine models of right ventricular pressure overload |
| Q52682504 | Bone Morphogenetic Protein 9 Reduces Cardiac Fibrosis and Improves Cardiac Function in Heart Failure. |
| Q35661775 | Cardiac Fibrosis Alleviated by Exercise Training Is AMPK-Dependent |
| Q38423895 | Cardiac fibroblast physiology and pathology |
| Q30467800 | Cardiac fibroblast: the renaissance cell |
| Q45786628 | Cardiac fibroblasts protect cardiomyocytes against lethal ischemia-reperfusion injury. |
| Q38118751 | Cardiac sodium channelopathy associated with SCN5A mutations: electrophysiological, molecular and genetic aspects |
| Q34189052 | Cardiac-specific mindin overexpression attenuates cardiac hypertrophy via blocking AKT/GSK3β and TGF-β1-Smad signalling. |
| Q97681476 | Cardioprotective effects of miR-34a silencing in a rat model of doxorubicin toxicity |
| Q33569405 | Cellular mechanisms of tissue fibrosis. 6. Purinergic signaling and response in fibroblasts and tissue fibrosis |
| Q35582221 | Changes in the myocardial interstitium and contribution to the progression of heart failure |
| Q45870342 | Chronic inhibition of cyclic guanosine monophosphate-specific phosphodiesterase 5 prevented cardiac fibrosis through inhibition of transforming growth factor β-induced Smad signaling |
| Q36464420 | Cinnamaldehyde attenuates pressure overload-induced cardiac hypertrophy |
| Q34990770 | Circulating microRNA expression profile and systemic right ventricular function in adults after atrial switch operation for complete transposition of the great arteries. |
| Q37466825 | Class I HDACs specifically regulate E-cadherin expression in human renal epithelial cells |
| Q39397020 | Computational Detection of Stage-Specific Transcription Factor Clusters during Heart Development. |
| Q27333630 | Culture-modified bone marrow cells attenuate cardiac and renal injury in a chronic kidney disease rat model via a novel antifibrotic mechanism |
| Q34676424 | Curcumin suppresses transforming growth factor-β1-induced cardiac fibroblast differentiation via inhibition of Smad-2 and p38 MAPK signaling pathways |
| Q83222670 | Cx43 contributes to TGF-beta signaling to regulate differentiation of cardiac fibroblasts into myofibroblasts |
| Q37671776 | DHA derivatives of fish oil as dietary supplements: a nutrition-based drug discovery approach for therapies to prevent metabolic cardiotoxicity |
| Q35854082 | DIM attenuates TGF-β1-induced myofibroblast differentiation in neonatal rat cardiac fibroblasts |
| Q35085132 | Decorin interacts with connective tissue growth factor (CTGF)/CCN2 by LRR12 inhibiting its biological activity |
| Q90848333 | Deficiency of NONO is associated with impaired cardiac function and fibrosis in mice |
| Q30838004 | Developmental stage-dependent effects of cardiac fibroblasts on function of stem cell-derived engineered cardiac tissues |
| Q38687425 | Diabetic cardiomyopathy: role of the E3 ubiquitin ligase |
| Q35315085 | Diastolic dysfunction is associated with cardiac fibrosis in the senescence-accelerated mouse |
| Q90382200 | Differential Role of TGF-β in Extracellular Matrix Regulation During Trypanosoma cruzi-Host Cell Interaction |
| Q64898891 | Directional Topography Influences Adipose Mesenchymal Stromal Cell Plasticity: Prospects for Tissue Engineering and Fibrosis. |
| Q42269363 | Disruption of tumor necrosis factor receptor associated factor 5 exacerbates pressure overload cardiac hypertrophy and fibrosis |
| Q48247203 | Dracorhodin Perchlorate Accelerates Cutaneous Wound Healing in Wistar Rats. |
| Q34684651 | Effects of tanshinone IIA on the transforming growth factor β1/Smad signaling pathway in rat cardiac fibroblasts |
| Q38074721 | Endoglin for tumor imaging and targeted cancer therapy. |
| Q36825271 | Endoglin: a critical mediator of cardiovascular health |
| Q54365023 | Epicardium is required for sarcomeric maturation and cardiomyocyte growth in the ventricular compact layer mediated by transforming growth factor β and fibroblast growth factor before the onset of coronary circulation. |
| Q90195274 | FGF23-Mediated Activation of Local RAAS Promotes Cardiac Hypertrophy and Fibrosis |
| Q58571180 | Fibroblast growth factor-2, but not the adipose tissue-derived stromal cells secretome, inhibits TGF-β1-induced differentiation of human cardiac fibroblasts into myofibroblasts |
| Q38057701 | Fibrosis and heart failure |
| Q90536651 | Flavonoid Extract from Propolis Inhibits Cardiac Fibrosis Triggered by Myocardial Infarction through Upregulation of SIRT1 |
| Q33567499 | Fra-2 mediates oxygen-sensitive induction of transforming growth factor beta in cardiac fibroblasts |
| Q90131243 | Function analysis of differentially expressed microRNAs in TGF-β1-induced cardiac fibroblasts differentiation |
| Q44853264 | GWAS or Gee Whiz, PSAS or Pshaw: elucidating the biologic and clinical significance of genetic variation in cardiovascular disease. |
| Q89294531 | Genetic Regulation of Fibroblast Activation and Proliferation in Cardiac Fibrosis |
| Q33611071 | Human cardiac fibroblasts adaptive responses to controlled combined mechanical strain and oxygen changes in vitro. |
| Q35192817 | Hydrogen sulfide alleviates myocardial collagen remodeling in association with inhibition of TGF-β/Smad signaling pathway in spontaneously hypertensive rats |
| Q35223551 | Hypoxia preconditioned mesenchymal stem cells prevent cardiac fibroblast activation and collagen production via leptin |
| Q44622680 | IL-1β suppresses TGF-β-mediated myofibroblast differentiation in cardiac fibroblasts. |
| Q36492742 | IRAK4 deficiency promotes cardiac remodeling induced by pressure overload |
| Q91644915 | In vivo and in vitro Approaches Reveal Novel Insight Into the Ability of Epicardium-Derived Cells to Create Their Own Extracellular Environment |
| Q39149965 | In-Vivo Assessment of Regional Mechanics Post-Myocardial Infarction: A Focus on the Road Ahead |
| Q90347777 | Inducing Endogenous Cardiac Regeneration: Can Biomaterials Connect the Dots? |
| Q54562352 | Inhibition of Toll-like receptor 2 reduces cardiac fibrosis by attenuating macrophage-mediated inflammation. |
| Q50994524 | Inhibition of the angiotensin-converting enzyme decreases skeletal muscle fibrosis in dystrophic mice by a diminution in the expression and activity of connective tissue growth factor (CTGF/CCN-2). |
| Q88726712 | Inhibitor of lysyl oxidase improves cardiac function and the collagen/MMP profile in response to volume overload |
| Q38423864 | Intracellular signaling of cardiac fibroblasts |
| Q33586605 | Intramyocardial fibroblast myocyte communication |
| Q46190199 | Lysosomal cysteine peptidase cathepsin L protects against cardiac hypertrophy through blocking AKT/GSK3beta signaling |
| Q34314334 | Mathematical model of renal interstitial fibrosis |
| Q35913023 | Mechanism of fibrotic cardiomyopathy in mice expressing truncated Rho-associated coiled-coil protein kinase 1. |
| Q38532876 | Mechanoregulation of cardiac myofibroblast differentiation: implications for cardiac fibrosis and therapy |
| Q47136571 | MicroRNA-130a, a Potential Antifibrotic Target in Cardiac Fibrosis |
| Q42089703 | MicroRNA-24 regulates cardiac fibrosis after myocardial infarction |
| Q42079784 | MicroRNA-9 inhibits high glucose-induced proliferation, differentiation and collagen accumulation of cardiac fibroblasts by down-regulation of TGFBR2. |
| Q90348644 | Molecular determinants of mesenchymal cell activation in fibroproliferative diseases |
| Q91557750 | Molecular mechanisms of arrhythmogenic cardiomyopathy |
| Q91393765 | Multipoint targeting of TGF-β/Wnt transactivation circuit with microRNA 384-5p for cardiac fibrosis |
| Q37176440 | Myocardial repair: from salvage to tissue reconstruction |
| Q27692541 | Myofibroblasts: trust your heart and let fate decide. |
| Q37641668 | Neferine inhibits proliferation and collagen synthesis induced by high glucose in cardiac fibroblasts and reduces cardiac fibrosis in diabetic mice |
| Q34664054 | Omega-3 fatty acids prevent pressure overload-induced cardiac fibrosis through activation of cyclic GMP/protein kinase G signaling in cardiac fibroblasts |
| Q41914494 | Opening of the inward rectifier potassium channel alleviates maladaptive tissue repair following myocardial infarction |
| Q43246929 | Oxidative stress, fibrosis, and early afterdepolarization-mediated cardiac arrhythmias. |
| Q36921222 | Pathobiology of transforming growth factor beta in cancer, fibrosis and immunologic disease, and therapeutic considerations |
| Q47200001 | Physiologic, Pathologic, and Therapeutic Paracrine Modulation of Cardiac Excitation-Contraction Coupling. |
| Q36583294 | Plakophilin-2 loss promotes TGF-β1/p38 MAPK-dependent fibrotic gene expression in cardiomyocytes. |
| Q43093520 | Prostacyclin receptor suppresses cardiac fibrosis: role of CREB phosphorylation |
| Q57821113 | Proteasome biology and therapeutics in cardiac diseases |
| Q36854082 | Rad GTPase inhibits cardiac fibrosis through connective tissue growth factor |
| Q36640570 | Reduced endoglin activity limits cardiac fibrosis and improves survival in heart failure |
| Q35026300 | Reducing endoglin activity limits calcineurin and TRPC-6 expression and improves survival in a mouse model of right ventricular pressure overload |
| Q35889807 | Resveratrol ameliorates myocardial fibrosis by inhibiting ROS/ERK/TGF-β/periostin pathway in STZ-induced diabetic mice. |
| Q91641055 | Resveratrol and Diabetic Cardiomyopathy: Focusing on the Protective Signaling Mechanisms |
| Q37139674 | Retinoic acid and sodium butyrate suppress the cardiac expression of hypertrophic markers and proinflammatory mediators in Npr1 gene-disrupted haplotype mice |
| Q33569387 | Role for high-glucose-induced protein O-GlcNAcylation in stimulating cardiac fibroblast collagen synthesis |
| Q42138480 | Role of T cell TGFbeta signaling and IL-17 in allograft acceptance and fibrosis associated with chronic rejection |
| Q36887421 | Spirolactone provides protection from renal fibrosis by inhibiting the endothelial-mesenchymal transition in isoprenaline-induced heart failure in rats |
| Q50851328 | Stretch-induced upregulation of connective tissue growth factor in rabbit cardiomyocytes. |
| Q40748178 | TGF-β receptor type II costameric localization in cardiomyocytes and host cell TGF-β response is disrupted by Trypanosoma cruzi infection |
| Q33761160 | TGF-β1 as possible link between loss of bone mineral density and chronic inflammation |
| Q42639607 | TGFbeta neutralization within cardiac allografts by decorin gene transfer attenuates chronic rejection |
| Q35192600 | TSC-22 promotes transforming growth factor β-mediated cardiac myofibroblast differentiation by antagonizing Smad7 activity. |
| Q33639481 | Targeting Adenosine Receptors for the Treatment of Cardiac Fibrosis |
| Q37519016 | Targeting LOXL2 for cardiac interstitial fibrosis and heart failure treatment |
| Q92327108 | The Role of Cyclic AMP Signaling in Cardiac Fibrosis |
| Q36609104 | The cyclic AMP effector Epac integrates pro- and anti-fibrotic signals |
| Q48153474 | The effects of intravenous anesthetics on mouse embryonic fibroblast viability and proliferation |
| Q33991229 | The role of SnoN in transforming growth factor beta1-induced expression of metalloprotease-disintegrin ADAM12. |
| Q35065245 | The role of TGFβ1 and LRG1 in cardiac remodelling and heart failure. |
| Q39827075 | The role of c-Jun N-terminal kinases 1/2 in transforming growth factor beta(1)-induced expression of connective tissue growth factor and scar formation in the cornea |
| Q38034004 | The role of cardiac fibroblasts in the transition from inflammation to fibrosis following myocardial infarction |
| Q34064815 | Thymosin beta 4 prevents oxidative stress by targeting antioxidant and anti-apoptotic genes in cardiac fibroblasts |
| Q51761633 | Tissue stiffness, latent TGF-beta1 activation, and mechanical signal transduction: implications for the pathogenesis and treatment of fibrosis. |
| Q82420426 | Transforming growth factor beta 1 (TGF-beta 1) in atrial fibrillation and acute congestive heart failure |
| Q34408710 | Transforming growth factor β1 inhibits bone morphogenic protein (BMP)-2 and BMP-7 signaling via upregulation of Ski-related novel protein N (SnoN): possible mechanism for the failure of BMP therapy? |
| Q44748423 | Treatment with cardiotonic pills(®) after ischemia-reperfusion ameliorates myocardial fibrosis in rats |
| Q36747783 | Unique mechanistic insights into the beneficial effects of soluble epoxide hydrolase inhibitors in the prevention of cardiac fibrosis |
| Q64097783 | Vascular peroxidase 1 is a novel regulator of cardiac fibrosis after myocardial infarction |
| Q92534487 | WWP2 regulates pathological cardiac fibrosis by modulating SMAD2 signaling |
Search more.